Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,04 USD | +0,66 % | +10,14 % | -4,40 % |
07/03 | Lumos Pharma, Inc. Informa de los resultados de beneficios para el año completo finalizado el 31 de diciembre de 2023 | CI |
07/03 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
Resumen de negocios
Número de empleados: 33
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Hawkins
CEO | Chief Executive Officer | 75 | 01/09/10 |
Lori Lawley
DFI | Director of Finance/CFO | 40 | 01/03/20 |
John McKew
PSD | President | 59 | 01/01/16 |
Chief Tech/Sci/R&D Officer | - | 01/05/22 | |
Bradley Powers
CMP | Compliance Officer | 45 | 03/08/19 |
Robert J. Davis
COO | Chief Operating Officer | - | 01/05/20 |
Lisa Miller
IRC | Investor Relations Contact | - | - |
Eddie L. Varnado
AUD | Comptroller/Controller/Auditor | - | 19/04/21 |
Aaron Schuchart
PRN | Corporate Officer/Principal | 59 | 06/05/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lota Zoth
BRD | Director/Board Member | 64 | 01/11/12 |
Richard Hawkins
CEO | Chief Executive Officer | 75 | 01/09/10 |
Kevin Lalande
BRD | Director/Board Member | 51 | 01/01/14 |
Thomas Raffin
BRD | Director/Board Member | 77 | 01/01/99 |
Joseph McCracken
BRD | Director/Board Member | 70 | 23/03/20 |
Director/Board Member | 64 | 13/02/21 | |
Director/Board Member | 45 | 01/03/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 8 139 661 | 5 289 307 ( 64,98 %) | 23 173 ( 0,2847 %) | 64,98 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,40 % | 24,51 M | |
+26,28 % | 42,68 mil M | |
-3,99 % | 42,4 mil M | |
+45,32 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+6,36 % | 24,94 mil M | |
-21,47 % | 18,96 mil M | |
+27,58 % | 12,3 mil M | |
-2,75 % | 11,95 mil M | |
-2,02 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción LUMO
- Empresa Lumos Pharma, Inc.